Stephanie Mehlis to Psoriasis
This is a "connection" page, showing publications Stephanie Mehlis has written about Psoriasis.
Connection Strength
1.114
-
Biologics for the primary care physician: Review and treatment of psoriasis. Dis Mon. 2019 Mar; 65(3):51-90.
Score: 0.524
-
From laboratory to clinic: rationale for biologic therapy. Dermatol Clin. 2004 Oct; 22(4):371-7, vii-viii.
Score: 0.201
-
The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol. 2003 Aug; 49(2 Suppl):S44-50.
Score: 0.186
-
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1693-1699.
Score: 0.123
-
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol. 2011 Sep; 165(3):652-60.
Score: 0.081